Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus

Maria Isabel Fiel, Kaushik Agarwal, Carmen Stanca, Nassim Eihaji, Nikolas Kontorinis, Swan N. Thung, Thomas D. Schiano

Research output: Contribution to journal › Article › peer-review

103 Scopus citations

Fingerprint

Dive into the research topics of 'Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus'. Together they form a unique fingerprint.

Medicine & Life Sciences